Benign prostatic hyperplasia. Part 1--diagnosis.
作者信息
Wilt Timothy J, N'Dow James
机构信息
Center for Chronic Disease Outcomes Research, 1 Veterans Drive (111-0), Minneapolis, MN 55417, USA.
出版信息
BMJ. 2008 Jan 19;336(7636):146-9. doi: 10.1136/bmj.39421.685023.AE.
Abstract
摘要
相似文献
1
Benign prostatic hyperplasia. Part 1--diagnosis.良性前列腺增生。第一部分——诊断。
BMJ. 2008 Jan 19;336(7636):146-9. doi: 10.1136/bmj.39421.685023.AE.
2
[Male lower urinary tract symptoms: the role of the prostate].[男性下尿路症状：前列腺的作用]
MMW Fortschr Med. 2013 Aug 22;155(14):34. doi: 10.1007/s15006-013-2036-0.
3
[Benign hypertrophy of the prostate].[前列腺良性增生]
Rev Prat. 2006 Dec 31;56(20):2283-9.
4
Arteriosclerosis related factors had no clinical significant correlation with resistive index in symptomatic benign prostatic hyperplasia.动脉硬化相关因素与症状性良性前列腺增生的阻力指数无临床显著相关性。
Urology. 2011 Feb;77(2):433-7. doi: 10.1016/j.urology.2010.04.065. Epub 2010 Dec 18.
5
Etiology, epidemiology, and natural history of benign prostatic hyperplasia.良性前列腺增生的病因、流行病学和自然史。
Urol Clin North Am. 2009 Nov;36(4):403-15, v. doi: 10.1016/j.ucl.2009.07.003.
6
[Urinary retention].[尿潴留]
Nihon Rinsho. 2013 Jun;71(6):1024-6.
7
Urodynamic effects of once daily tadalafil in men with lower urinary tract symptoms secondary to clinical benign prostatic hyperplasia: a randomized, placebo controlled 12-week clinical trial.每日一次他达拉非治疗临床良性前列腺增生症下尿路症状患者的尿动力学效果：一项随机、安慰剂对照的 12 周临床试验。
J Urol. 2010 Mar;183(3):1092-7. doi: 10.1016/j.juro.2009.11.014. Epub 2010 Jan 25.
8
Role of invasive urodynamic testing in benign prostatic hyperplasia and male lower urinary tract symptoms.在良性前列腺增生和男性下尿路症状中的侵入性尿动力学检查的作用。
Urol Clin North Am. 2009 Nov;36(4):431-41, v. doi: 10.1016/j.ucl.2009.07.002.
9
[Etiology and diagnostics of the benign prostate syndrom].[良性前列腺综合征的病因及诊断]
MMW Fortschr Med. 2013 Aug 22;155(14):35-8. doi: 10.1007/s15006-013-2037-z.
10
[Benign prostatic hyperplasia: background and diagnosis].[良性前列腺增生：背景与诊断]
MMW Fortschr Med. 2007 Aug 16;149(33-34):25-8.
引用本文的文献
1
[Quality of care indicators for benign prostatic hyperplasia. A qualitative study].[良性前列腺增生的医疗质量指标。一项定性研究]
Aten Primaria. 2014 May;46(5):231-7. doi: 10.1016/j.aprim.2013.09.005. Epub 2013 Dec 15.
2
Measurement of tamsulosin in human serum by liquid chromatography-tandem mass spectrometry.液相色谱-串联质谱法测定人血清中的坦索罗辛。
J Chromatogr B Analyt Technol Biomed Life Sci. 2013 Jul 1;930:121-8. doi: 10.1016/j.jchromb.2013.04.020. Epub 2013 Apr 19.
3
Benign prostatic hyperplasia: The term BPH is misused.良性前列腺增生：术语“BPH”被误用了。
BMJ. 2008 Feb 23;336(7641):405. doi: 10.1136/bmj.39493.447361.1F.
4
Benign prostatic hyperplasia: You have to put your finger in.良性前列腺增生：你得把手指伸进去。
BMJ. 2008 Feb 2;336(7638):232-3. doi: 10.1136/bmj.39471.690440.3A.
5
Benign prostatic hyperplasia. Part 2--management.良性前列腺增生。第2部分——管理
BMJ. 2008 Jan 26;336(7637):206-10. doi: 10.1136/bmj.39433.670718.AD.
本文引用的文献
1
Prevalence of lower urinary tract symptoms and effect on quality of life in a racially and ethnically diverse random sample: the Boston Area Community Health (BACH) Survey.不同种族和民族随机样本中下尿路症状的患病率及其对生活质量的影响：波士顿地区社区健康（BACH）调查
Arch Intern Med. 2006 Nov 27;166(21):2381-7. doi: 10.1001/archinte.166.21.2381.
2
Clinically localised prostate cancer.临床局限性前列腺癌
BMJ. 2006 Nov 25;333(7578):1102-6. doi: 10.1136/bmj.39022.423588.DE.
3
Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study.五个国家基于人群的尿失禁、膀胱过度活动症及其他下尿路症状调查：EPIC研究结果
Eur Urol. 2006 Dec;50(6):1306-14; discussion 1314-5. doi: 10.1016/j.eururo.2006.09.019. Epub 2006 Oct 2.
4
The natural history of benign prostatic hyperplasia.良性前列腺增生的自然病史。
BJU Int. 2006 Apr;97 Suppl 2:3-6; discussion 21-2. doi: 10.1111/j.1464-410X.2006.06097.x.
5
History of weight and obesity through life and risk of benign prostatic hyperplasia.一生中体重与肥胖的病史及良性前列腺增生的风险
Int J Obes (Lond). 2005 Jul;29(7):798-803. doi: 10.1038/sj.ijo.0802979.
6
Counting the cost of treating benign prostatic hyperplasia.计算良性前列腺增生的治疗成本。
BJU Int. 2004 Feb;93(3):250-2. doi: 10.1111/j.1464-410x.2004.04595.x.
7
The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia.多沙唑嗪、非那雄胺及联合治疗对良性前列腺增生临床进展的长期影响。
N Engl J Med. 2003 Dec 18;349(25):2387-98. doi: 10.1056/NEJMoa030656.
8
The fear of prostate cancer in men with lower urinary tract symptoms: should symptomatic men be screened?下尿路症状男性对前列腺癌的恐惧：有症状的男性是否应接受筛查？
BJU Int. 2003 Jan;91(1):30-2. doi: 10.1046/j.1464-410x.2003.04013.x.
9
Quality control in urodynamics: a review of urodynamic traces from one centre.尿动力学中的质量控制：来自一个中心的尿动力学记录综述
BJU Int. 2003 Feb;91(3):201-7. doi: 10.1046/j.1464-410x.2003.04054.x.
10
Prevalence of and racial/ethnic variation in lower urinary tract symptoms and noncancer prostate surgery in U.S. men.美国男性下尿路症状及非癌性前列腺手术的患病率和种族/民族差异
Urology. 2002 Jun;59(6):877-83. doi: 10.1016/s0090-4295(01)01673-9.
Zotero 插件